EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,139,661 | +406.1% | 97,925 | +342.6% | 0.20% | +400.0% |
Q2 2023 | $422,771 | +140.2% | 22,123 | +101.6% | 0.04% | +21.2% |
Q4 2022 | $175,975 | -17.8% | 10,971 | -19.8% | 0.03% | -25.0% |
Q3 2022 | $214,000 | -22.7% | 13,672 | +2.6% | 0.04% | -58.5% |
Q2 2022 | $277,000 | +3.0% | 13,324 | +12.3% | 0.11% | +5.0% |
Q1 2022 | $269,000 | +26.9% | 11,869 | -1.5% | 0.10% | +71.2% |
Q4 2019 | $212,000 | -59.2% | 12,052 | -59.0% | 0.06% | -55.6% |
Q3 2019 | $520,000 | -50.5% | 29,418 | -39.7% | 0.13% | -15.3% |
Q2 2018 | $1,050,000 | +80.1% | 48,773 | +85.3% | 0.16% | +12.1% |
Q1 2018 | $583,000 | -27.8% | 26,322 | -1.0% | 0.14% | -71.3% |
Q4 2017 | $808,000 | – | 26,578 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |